|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe ITEM-2 antibody reacts with human TWEAK Receptor/Fn14 (fibroblast growth factor-inducable 14 kDa protein) and cross-reacts with the mouse antigen. Fn14 is distantly related to the TNFR family, containing one cysteine-rich domain in the extracellular region and a TNFR-associated factor binding domain but does not contain a death domain (DD) cytoplasmic region. Fn14 plays a role in TWEAK-induced endothelial cell migration, proliferation, and angiogenesis. TWEAK-induced cell death via Fn14 includes both apoptosis and necrosis and can be blocked by an anti-TWEAK antibody, CARL-1 (Cat. No. 16-9915). Fn14 is expressed on HUVEC and in some cancer tissues but not on freshly isolated PBMCs. Fn14 mRNA expression has been identified during liver regeneration. In the mouse, Fn14 is reported to be constitutively expressed by Colon 26 cell line. ITEM-2 is reported to act as an antagonist in in vitro functional assays. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The ITEM-2 antibody has been reported for use in flow cytometric analysis. It has also been reported in in vitro blocking of mouse/human Fn14. Applications TestedThe ITEM-2 antibody has been tested by flow cytometric analysis of human Fn14 transfected cells. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Nakayama, M., K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, K. Okumura, H. Yagita. 2003. Fibroblast Growth Factor-Inducible 14 Mediates Multiple Pathways of TWEAK-Induced Cell Death. The Journal of Immunology, 170: 341-348. Harada N., M. Nakayama, H. Nakano, Y. Fukuchi, H. Yagita, K. Okumura. 2002. Pro-inflammatory Effect of TWEAK/Fn14 Interaction on Human Umbilical Vein Endothelial Cells. Biochem Biophys Res Commun, 299(3):488-93. Nakayama M, K. Ishidoh, N. Kayagaki, Y. Kojima, N. Yamaguchi, H. Nakano, E. Kominami, K. Okumura, H. Yagita. 2002. Multiple pathways of TWEAK-induced cell death. J Immunol, 168(2):734-43 Related ProductsCat. 11-4204 Fluorescein isothiocyanate (FITC) anti-mouse IgA (clone mA-6E1) Cat. 11-4317 Streptavidin-FITC (Fluorescein isothiocyanate) Cat. 12-4317 Streptavidin-PE (Phycoerythrin) Cat. 17-4317 Streptavidin Allophycocyanin (SA-APC) Cat. 13-5994 Biotin anti-mouse IgA (clone 11-44-2) Cat. 12-9018 PE anti-human and mouse Fn14/TWEAK Receptor (CD266, TWEAKR, Fn-14) (clone ITEM-4) Cat. 13-9018 Biotin anti-human and mouse Fn14/TWEAK Receptor (CD266, TWEAKR, Fn-14) (clone ITEM-4) Cat. 14-9018 Affinity Purified anti-human and mouse Fn14/TWEAK Receptor (CD266, TWEAKR, Fn-14) (clone ITEM-4) |
||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2009 eBioscience, Inc. For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent. |